API VS Intermediates: the Difference Between Them
- Categories:NEWS
- Author:
- Origin:
- Time of issue:2022-11-29
- Views:0
(Summary description)An intermediate is an intermediate compound produced during the production of an active pharmaceutical ingredient (API). Pharmaceutical intermediates are by-products produced during the production of APIs.
API VS Intermediates: the Difference Between Them
(Summary description)An intermediate is an intermediate compound produced during the production of an active pharmaceutical ingredient (API). Pharmaceutical intermediates are by-products produced during the production of APIs.
- Categories:NEWS
- Author:
- Origin:
- Time of issue:2022-11-29
- Views:0
What is an intermediate?
An intermediate is an intermediate compound produced during the production of an active pharmaceutical ingredient (API). Pharmaceutical intermediates are by-products produced during the production of APIs. Each reaction in the API production process produces several different intermediates, which can also be used as precursors for other active pharmaceutical ingredients. Intermediates can and are used not only in the production of APIs, but also by various pharmaceutical and biopharmaceutical companies for R&D or therapeutic purposes.
What is an API?
API (active pharmaceutical ingredient) is the active ingredient contained in a drug. Any substance or mixture of substances intended to be used in the manufacture of a drug (drug), when used in the manufacture of a drug, will be the active ingredient in the drug product. Such substances are intended to provide pharmacological activity or other direct action for the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or function of the body.
Difference between APIs and intermediates
Although both APIs and intermediates have pharmacological activity, they also have many differences, which are reflected in the following areas.
Applications
APIs are the end product of raw materials that are usually safe and properly studied for therapeutic purposes. Intermediates, on the other hand, are by-products of the API manufacturing process and may be therapeutic, toxic, or even API. API produced as a by-product cannot be administered or used as an active ingredient without official approval.
New Drug Development
APIs are compounds that have undergone adequate pharmacological studies and can be safely used in humans for therapeutic diagnosis. Pharmaceutical intermediates are compounds in the synthesis of APIs that may not have therapeutic effects or are toxic. However, some intermediates in the synthesis of APIs are also APIs.
Drug Regulatory
API must be registered with the drug regulatory authority according to the law and synthesized in a GMP-compliant plant after obtaining an approval number. The intermediate is only a by-product of the API synthesis process and does not need to obtain an approval number. It is important to note that some compounds, although the same as APIs, are not APIs if they do not have an approval number or are not produced in a GMP facility.
For more information please visit this link.
Scan the QR code to read on your phone
ABOUT US
Hebei Haili fragrances Co., Ltd. was established in December 2003, covering an area of 26700m2, with a registered capital of 40.2 million, 281 employees and a sales volume of 198 million in 2019.
The company specializes in the development, production and sales of chemical APIs, spices, polyimide monomers.
WHY CHOOSE US

CONTACT US
NEWS LETTER
We are willing to communicate extensively with friends from all walks of life at home and abroad to work together to create a better future.
Copyright: Hebei Haili Fragrances Co.,Ltd 冀ICP備11016002號-1 Powered by www.300.cn